General information

Canopy Growth Corporation, through its subsidiaries, is a producer of medical marijuana. The Company`s group of brands represents distinct voices and market positions designed to appeal to an array of customers, doctors and strategic industry partners.
  • Current market environment: negative. Prices of production are 27.8% lower compared to the last 12 months (LTM)
  • Prices of production are at 0.0% percentile over the past 5 years, adjusted for inflation (are close to minimun)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield -84.4% (LTM), projected -101.5%
  • Share price is 7.4% higher than minimum and 93.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-2.6x vs
  • The company is undervalued by EV / projected EBITDA multiple compared to target level (

Key Financials (Download financials)

Ticker: CGC
Share price, USD:  (-3.0%)3.5
year average price 10.75  

year start price 24.18 2021-06-30

max close price 24.18 2021-06-30

min close price 3.26 2022-06-16

current price 3.50 2022-06-30
Common stocks: 372 244 566

Dividend Yield:  0.0%
FCF Yield LTM / expected: -84.4% / -101.5%
EV / LTM EBITDA: -2.6x
Production prices change from LTM: -27.8%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 1 303
Net Debt ($m): 725
EV (Enterprise Value): 2 028
EBITDA LTM ($m): -772
EV / LTM EBITDA: -2.6x
Price to Book: 0.39x

Short interest: 11.1%

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF / Free Cash Flow ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 50% percentile

Potential dynamics


2022-06-29The Motley Fool

Can These Beaten-Down Growth Stocks Be Revived?

2022-06-28The Motley Fool

Why Canopy Growth Stock Couldn't Catch a Buzz Today

2022-06-28Market Watch

Canopy Growth credit rating hit on market share losses in Canadian cannabis market


The CLIMB Act May Help Marijuana Stocks Trade Better

2022-06-21Seeking Alpha

Cannabis REITs: Weeding Out The Weak

2022-06-14The Motley Fool

Here's Why Tilray and Canopy Growth Jumped Tuesday but Hexo Crashed

2022-06-10Schaeffers Research

This Week's Cannabis Stock News: 7 Companies Make Headlines

2022-06-08The Motley Fool

Here's 1 Stock I'd Avoid at All Costs


Top Canadian Marijuana Stocks On The Nasdaq In June

2022-06-02The Motley Fool

2 Extremely Concerning Metrics From This Growth Stock's Q4 Results
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company